Engineered E. coli Nissle 1917 for the reduction of vancomycin-resistant in the intestinal tract

about

Engineered E. coli Nissle 1917 for the reduction of vancomycin-resistant in the intestinal tract

Item

http://www.wikidata.org/entity/Q58127281

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Engineered E. coli Nissle 1917 ...... istant in the intestinal tract

@en

Engineered E. coli Nissle 1917 ...... istant in the intestinal tract

@nl

type

Item

label

Engineered E. coli Nissle 1917 ...... istant in the intestinal tract

@en

Engineered E. coli Nissle 1917 ...... istant in the intestinal tract

@nl

prefLabel

Engineered E. coli Nissle 1917 ...... istant in the intestinal tract

@en

Engineered E. coli Nissle 1917 ...... istant in the intestinal tract

@nl

P1476

Engineered E. coli Nissle 1917 ...... istant in the intestinal tract

@en

P2093

Gary M Dunny

http://www.w3.org/2001/XMLSchema#string

Kathryn G Geldart

http://www.w3.org/2001/XMLSchema#string

Madeline Forbes

http://www.w3.org/2001/XMLSchema#string

Michael Hayward

http://www.w3.org/2001/XMLSchema#string

Nita H Salzman

http://www.w3.org/2001/XMLSchema#string

Sushma Kommineni

http://www.w3.org/2001/XMLSchema#string

P2860

BACTIBASE second release: a database and tool platform for bacteriocin characterization

Bacterial Secretion Systems: An Overview

Insights from 100 Years of Research with Probiotic E. Coli

Microcins, gene-encoded antibacterial peptides from enterobacteria.

Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models.

Genetic analysis of an MDR-like export system: the secretion of colicin V.

A family of bacteriocin ABC transporters carry out proteolytic processing of their substrates concomitant with export.

The binding interaction of Coomassie blue with proteins.

Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans.

Targeted quantitation of proteins by mass spectrometry.

P304

197-208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BTM2.10107

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yiannis N Kaznessis

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30377660

http://www.w3.org/2001/XMLSchema#string

P921

Escherichia coli

P932

6195901

http://www.w3.org/2001/XMLSchema#string